Can Voluntary Third Party Inspections Cure FDA’s Inspection Woes?

FDA's third party 510(k) review program provides a successful model for the agency to pattern third party inspections, National Electrical Manufacturers Association VP Robert Britain told the HHS Secretary's Advisory Committee on Regulatory Reform at its inaugural meeting in Washington, DC

More from Archive

More from Medtech Insight